Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet Sells 3,031 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 3,031 shares of the business’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $577.30, for a total value of $1,749,796.30. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at approximately $203,786.90. This represents a 89.57 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Myriam Curet also recently made the following trade(s):

• On Thursday, February 27th, Myriam Curet sold 2,401 shares of Intuitive Surgical stock. The shares were sold at an average price of $581.00, for a total value of $1,394,981.00.
• On Tuesday, February 11th, Myriam Curet sold 408 shares of Intuitive Surgical stock. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00.

Intuitive Surgical Stock Down 1.1 %

Shares of ISRG stock opened at $566.98 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The firm has a fifty day moving average of $570.66 and a 200-day moving average of $530.08. The firm has a market capitalization of $201.95 billion, a price-to-earnings ratio of 88.45, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Atala Financial Inc bought a new stake in shares of Intuitive Surgical in the fourth quarter worth $25,000. Berbice Capital Management LLC acquired a new position in Intuitive Surgical during the fourth quarter valued at approximately $26,000. Parvin Asset Management LLC bought a new position in Intuitive Surgical in the fourth quarter valued at approximately $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $28,000. Finally, Hurley Capital LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $28,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research analyst reports. Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. BTIG Research increased their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. UBS Group boosted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Finally, JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.